NCT05242458View on ClinicalTrials.gov

A Study of Ustekinumab Treatment in Children With Crohn's Disease

CompletedOBSERVATIONAL
Enrollment

545

Participants

Timeline

Start Date

March 21, 2022

Primary Completion Date

May 22, 2023

Study Completion Date

May 22, 2023

Conditions
Crohn's Disease
Interventions
DRUG

Ustekinumab

No interventions will be administered as a part of this study. Participants will receive ustekinumab as per their routine clinical practice.

Trial Locations (1)

05408

ImproveCareNow, Inc., Burlington

All Listed Sponsors
collaborator

ImproveCareNow (ICN)

OTHER

collaborator

Children's Hospital Medical Center, Cincinnati

OTHER

lead

Janssen Research & Development, LLC

INDUSTRY